News & Events

UCSF News reports on the "TOGA" study led by Stanley Rogers, MD, FACS , Associate Clinical Professor of Surgery and Co-Director of the UCSF Bariatric Surgery Center, and John Cello, MD, Professor of Medicine and Surgery, and Medical Director of Bariatric Surgery Center. The investigational procedure, transoral...

Despite substantial research showing that Peripheral artery disease (PAD) puts people at increased risk for heart attack, stroke, amputation and other vascular-related coniditions, PAD remains significantly underdiaganosed and undertreated. “These are very vulnerable patients,” says Michael S. Conte, MD,, chief of...

UCSF vascular surgeons have introduced a new "flow reversal" system designed to improve the safety of carotid artery stenting procedures. The FDA approved the first flow reversal system for clinical use earlier this month based upon the results of a recently completed clinical trial. Flow reversal systems...

Michael Conte, M.D. has been named the Chief of the Division of Vascular & Endovascular Surgery. Dr. Conte was previously on the faculty at Brigham and Women's Hospital in Boston, Dr. Conte's clinical and research expertise encompass carotid artery disease, diabetic vascular disease, diseases of the aorta/visceral...

Nancy Ascher, MD, PhD on NPR's Forum with Michael Krasny Each day in the U.S., 19 people die waiting for donated organs. To help increase supply, some health experts and economists want to legalize the market for human organs. We take up the issue with a panel of experts.

"UCSF scientists have discovered that a gene controlling whether blood vessels differentiate into arteries or veins during embryonic development is linked to a vascular disorder in the brain that causes stroke. The UCSF studies were done in mice, and the new findings are the first to provide information on both...

Dr. Timothy A.M. Chuter was presented the Society for Vascular Surgery Medal for Innovation in Vascular Surgery at the 62nd Annual Meeting of the Society for Vascular Surgery on June 6, 2008. Dr. Chuter has been a leading developer of the technology utilized in endovascular treatment of vascular disease for over...

"International Stem Cell Corporation announced today that its human parthenogenetic stem cell lines will be used in studies aimed at creating liver cells to treat human liver disease. ...... Holger Willenbring, MD, UCSF assistant professor of surgery, will direct the research. "The fact that Dr. Willenbring and...

"We're glad to reach this significant point in our program because it means that a great number of patients are receiving improvements to their health that could not otherwise be achieved without an organ transplant," said Charles Hoopes, MD, director of Cardiopulmonary Transplantation at UCSF since 2002. "UCSF...

The San Francisco Examiner reports on the increase in violence from gunshot or stab wounds in patients admitted to SFGH: The number of victims with gunshot or stab wounds admitted to San Francisco General Hospital has climbed over the last five years, with more than 440 patients either shot or knifed in 2007. The...

The Wittgenstein Forum blog reports on a Nevada Appeal article highlighting the benfits of using cranial re-animation surgery to treat Mobius Syndrome, a rare birth defect caused by the absence or underdevelopment of cranial nerves that control eye movement and facial expression. The surgery is performed at UCSF...

Dr. Harrison helped change the face of medicine. Today, UCSF is building a medical complex where scientific innovations become life-saving treatments ...

UCSF has created a groundbreaking new procedure to treat chest deformities in children and teens. This minimally invasive procedure is already transforming one 14-year-old's life.

Dr. Nancy Ascher and Dr. Holger Willenbring were interviewed by PBS NewsHour correspondent Spencer Michaels about the transformation of embryonic stem cells into new liver cells as a treatment for patients.